Skip to main content

Table 4 Clinical outcomes of patients with versus without diabetes mellitus in the propensity matched population

From: Diabetes mellitus in transfemoral transcatheter aortic valve implantation: a propensity matched analysis

 

Diabetes

(n = 3281)

No diabetes (n = 3281)

RR

(95% CI)

p Value

Procedural

    

Conversion to open heart surgery

21 (0.7%)

19 (0.6%)

1.1 (0.6–2.1)

0.73

Mortality < 72h

48 (1.5%)

47 (1.5%)

1.0 (0.7–1.5)

0.92

During hospital admission

    

Mortality

147 (4.7%)

134 (4.3%)

1.1 (0.9–1.4)

0.38

Stroke

53 (1.7%)

65 (2.1%)

0.8 (0.6–1.2)

0.28

Myocardial infarction

24 (0.8%)

16 (0.5%)

1.5 (0.8–2.1)

0.21

Major or life-threatening bleeding

126 (4.4%)

158 (5.5%)

0.8 (0.6-1.0)

0.05

New onset atrial fibrillation

61 (7.8%)

65 (7.1%)

1.1 (0.8–1.6)

0.56

Permanent pacemaker implantation

400 (13.0%)

418 (13.6%)

1.0 (0.8–1.1)

0.51

Length of stay (days)

7 (5–11)

7 (5–11)

-

0.92

At 30 Days

    

Mortality

157 (5.6%)

160 (5.6%)

1.0 (0.8–1.2)

0.96

Stroke

65 (2.3%)

75 (2.6%)

0.9 (0.6–1.2)

0.47

At one year

    

Mortality

370 (17.3%)

349 (16.2%)

1.1 (0.9–1.2)

0.37

Stroke

107 (4.9%)

112 (5.2%)

1.0 (0.7–1.2)

0.75

  1. Incidence and relative risk of clinical outcomes in diabetic compared with non-diabetic patients. The propensity score included: age, sex, body mass index, a history of cerebrovascular events, myocardial infarction, coronary artery bypass graft, percutaneous coronary intervention, hypertension, dyslipidaemia, peripheral vascular disease, atrial fibrillation, renal failure, coronary artery disease, logistic EuroSCORE, mean aortic valve gradient, valve type (self or balloon expanding), valve generation, and year of procedure. RR: Relative Risk; CI: Confidence Interval